Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Regression Analysis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Registries < Regression Analysis < Remission Induction  Facettes :

List of bibliographic references indexed by Regression Analysis

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000881 (2019) Kathrine Lederballe Gr N [Oman] ; Elizabeth V. Arkema [Suède] ; Bente Glintborg [Danemark] ; Frank Mehnert [Danemark] ; Mikkel Stergaard [Danemark] ; Lene Dreyer [Danemark] ; Mette N Rgaard [Danemark] ; Niels Steen Krogh [Danemark] ; Johan Askling [Suède] ; Merete Lund Hetland [Danemark]Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden.
001264 (2018) Thomas Frisell [Suède] ; Eva Baecklund [Suède] ; Karin Bengtsson [Suède] ; Daniela Di Giuseppe [Suède] ; Helena Forsblad-D'Elia [Suède] ; Johan Askling [Suède]Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.
001561 (2017) Mari Kihara [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Lianne Kearsley-Fleet [Royaume-Uni] ; Kath D. Watson [Royaume-Uni] ; Mark Lunt [Royaume-Uni] ; Deborah P M. Symmons [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis.
001686 (2017) Simon Tarp [Danemark] ; Daniel Eric Furst [États-Unis] ; Maarten Boers ; George Luta [États-Unis] ; Henning Bliddal [Danemark] ; Ulrik Tarp ; Karsten Heller Asmussen [Danemark] ; Birgitte Brock ; Anna Dossing [Danemark] ; Tanja Schj Dt J Rgensen [Danemark] ; Steffen Thirstrup [Danemark] ; Robin Christensen [Danemark]Risk of serious adverse effects of biological and targeted drugs in patients with rheumatoid arthritis: a systematic review meta-analysis.
001B20 (2016) Glen S. Hazlewood [Canada] ; Cheryl Barnabe [Canada] ; George Tomlinson [Canada] ; Deborah Marshall [Canada] ; Dan Devoe [Canada] ; Claire Bombardier [Canada]Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis.
001F32 (2015) Kazuko Uno [Japon] ; Kazuyuki Yoshizaki [Japon] ; Mitsuhiro Iwahashi [Japon] ; Jiro Yamana [Japon] ; Seizo Yamana [Japon] ; Miki Tanigawa [Japon] ; Katsumi Yagi [Japon]Pretreatment Prediction of Individual Rheumatoid Arthritis Patients' Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptor Biomarkers.
002058 (2015) Helena Forsblad-D'Elia [Suède] ; Karin Bengtsson [Suède] ; Lars Erik Kristensen [Suède] ; Lennart T H. Jacobsson [Suède]Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis: results from the Swedish biologics register.
002082 (2015) Ingunn Fride Tvete [Norvège] ; Bent Natvig [Norvège] ; J Rund G Semyr [Norvège] ; Nils Meland [Norvège] ; Marianne R Ine [Norvège] ; Marianne Klemp [Norvège]Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis.
003857 (2011) Valentin Brodszky [Hongrie][Effectiveness of biological treatments based on ACR70 response in rheumatoid arthritis: indirect comparison and meta-regression using Bayes-model].
004289 (????) Eric Druyts [Canada] ; Jacqueline B. Palmer [États-Unis] ; Chakrapani Balijepalli [Canada] ; Keith Chan [Canada] ; Mir Sohail Fazeli [Canada] ; Vivian Herrera [États-Unis] ; Jeroen P. Jansen [Canada] ; Jay J H. Park [Canada] ; Steve Kanters [Canada] ; Andreas Reimold [États-Unis]Treatment modifying factors of biologics for psoriatic arthritis: a systematic review and Bayesian meta-regression.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Regression Analysis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Regression Analysis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Regression Analysis
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021